Published in Am J Physiol on March 01, 1977
Hemodynamic basis for glomerular injury in rats with desoxycorticosterone-salt hypertension. J Clin Invest (1984) 1.55
Hypertensive crisis in children. Pediatr Nephrol (2011) 1.07
The role of vasopressin in blood pressure regulation immediately following acute haemorrhage in the rat. J Physiol (1979) 1.06
Plasma vasopressin levels during hypoxaemia and the cardiovascular effects of exogenous vasopressin in foetal and adult sheep. J Physiol (1978) 0.99
Role of endothelin-1 and the ETA receptor in the maintenance of deoxycorticosterone acetate-salt-induced hypertension. Br J Pharmacol (1995) 0.90
Effect of intracerebroventricular benzamil on cardiovascular and central autonomic responses to DOCA-salt treatment. Am J Physiol Regul Integr Comp Physiol (2010) 0.88
Quantitative contribution of systemic vascular autoregulation in acute hypertension in conscious dogs. J Clin Invest (1989) 0.77
Vasopressin and the pathogenesis of chronic renal failure. Br J Pharmacol (1990) 0.77
Animal models for the study of primary and secondary hypertension in humans. Biomed Rep (2016) 0.75
Plasma vasopressin and blood pressure. Studies in normal subjects and in benign essential hypertension at rest and after postural challenge. Br Heart J (1983) 0.75
The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum (1996) 6.88
Mortality in systemic lupus erythematosus. Arthritis Rheum (2006) 3.61
Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome 1q in African-American pedigrees. Proc Natl Acad Sci U S A (1998) 3.35
Decreases in anti-double-stranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus. Arthritis Rheum (2001) 2.68
Risk factors for osteonecrosis in systemic lupus erythematosus. J Rheumatol (1997) 2.59
The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum (1997) 2.49
The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison. J Rheumatol (2000) 2.26
Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study. Arthritis Rheum (2007) 2.18
Cardiac involvement in systemic lupus erythematosus. Lupus (2005) 2.08
Damage in systemic lupus erythematosus and its association with corticosteroids. Arthritis Rheum (2000) 2.06
Baseline characteristics of a multiethnic lupus cohort: PROFILE. Lupus (2002) 2.03
A new subset of mineralocorticoid hypertension with excess of 21-deoxyaldosterone and Kelly's-M1 steroid: clinical and morphological findings. J Clin Endocrinol Metab (1995) 2.01
An international cohort study of cancer in systemic lupus erythematosus. Arthritis Rheum (2005) 1.96
Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus. Arthritis Care Res (Hoboken) (2010) 1.84
A decrease in complement is associated with increased renal and hematologic activity in patients with systemic lupus erythematosus. Arthritis Rheum (2001) 1.82
Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: implications for coagulation events and antigenic spread in systemic lupus erythematosus. Proc Natl Acad Sci U S A (1996) 1.82
The histologic spectrum of prepuces from patients with phimosis. Am J Dermatopathol (1988) 1.73
Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort. Genes Immun (2011) 1.70
European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies. Ann Rheum Dis (2009) 1.69
Pulmonary hypertension in systemic lupus erythematosus. J Rheumatol (1989) 1.67
Fatal infections in systemic lupus erythematosus: the role of opportunistic organisms. Medicine (Baltimore) (1987) 1.67
Accumulation of coronary artery disease risk factors over three years: data from an international inception cohort. Arthritis Rheum (2008) 1.65
Depressive symptoms in patients with systemic lupus erythematosus: association with central nervous system lupus and Sjögren's syndrome. J Rheumatol (1994) 1.54
Interferon regulatory factor-5 is genetically associated with systemic lupus erythematosus in African Americans. Genes Immun (2008) 1.53
Cyclophosphamide for lupus during pregnancy. Lupus (2005) 1.52
Atraumatic osteonecrosis of the humeral head. J Rheumatol (2000) 1.51
Immunoablative high-dose cyclophosphamide without stem-cell rescue for refractory, severe autoimmune disease. Ann Intern Med (1998) 1.51
The frequency of lupus anticoagulant in systemic lupus erythematosus. A study of sixty consecutive patients by activated partial thromboplastin time, Russell viper venom time, and anticardiolipin antibody level. Ann Intern Med (1987) 1.42
The relationship between cancer and medication exposures in systemic lupus erythaematosus: a case-cohort study. Ann Rheum Dis (2007) 1.37
Assessment of systemic lupus erythematosus. Clin Exp Rheumatol (2005) 1.37
Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus? Arthritis Rheum (2005) 1.35
Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study. Arthritis Rheum (2008) 1.34
Pharmacokinetics and pharmacodynamics of glucocorticoid suspensions after intra-articular administration. Clin Pharmacol Ther (1986) 1.32
Outcome measures to be used in clinical trials in systemic lupus erythematosus. J Rheumatol (1999) 1.29
Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus. Ann Rheum Dis (2009) 1.27
Non-tropical sprue. Malignant diseases and mortality rate. Scand J Gastroenterol (1985) 1.27
An update on mortality in systemic lupus erythematosus. Clin Exp Rheumatol (2008) 1.25
The systemic lupus erythematosus Tri-nation Study: absence of a link between health resource use and health outcome. Rheumatology (Oxford) (2004) 1.23
Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers. Lupus (2011) 1.23
Early prediction of outcome in head-injured patients. J Neurosurg (1981) 1.22
Randomized clinical trials and longitudinal observational studies in systemic lupus erythematosus: consensus on a preliminary core set of outcome domains. J Rheumatol (1999) 1.19
Mannose-binding protein genetic polymorphisms in black patients with systemic lupus erythematosus. Arthritis Rheum (1996) 1.18
Systemic lupus erythematosus one disease or many? Autoimmun Rev (2011) 1.18
Relationship between admission hyperglycemia and neurologic outcome of severely brain-injured patients. Ann Surg (1989) 1.17
International consensus for a definition of disease flare in lupus. Lupus (2010) 1.16
Hemodynamic effects of exogenous and endogenous vasopressin at low plasma concentrations in conscious dogs. Circ Res (1980) 1.15
Effect of intravenous insulin infusion on mortality among diabetic patients after myocardial infarction. Br Heart J (1984) 1.14
The DNA mismatch repair enzyme PMS1 is a myositis-specific autoantigen. Arthritis Rheum (2001) 1.14
An assessment of disease flare in patients with systemic lupus erythematosus: a comparison of BILAG 2004 and the flare version of SELENA. Ann Rheum Dis (2010) 1.12
The effectiveness of mycophenolate mofetil in refractory pyoderma gangrenosum. Arch Dermatol (1998) 1.12
Greatly enhanced pressor response to antidiuretic hormone in patients with impaired cardiovascular reflexes due to idiopathic orthostatic hypotension. J Cardiovasc Pharmacol (1980) 1.10
Peripheral neuropathies in systemic lupus erythematosus: clinical features, disease associations, and immunologic characteristics evaluated over a twenty-five-year study period. Arthritis Rheumatol (2014) 1.08
Failure of prophylactically administered phenytoin to prevent late posttraumatic seizures. J Neurosurg (1983) 1.07
Plasma vasopressin concentrations and effects of vasopressin antiserum on blood pressure in rats with malignant two-kidney Goldblatt hypertension. Circ Res (1978) 1.07
Evolution of disease burden over five years in a multicenter inception systemic lupus erythematosus cohort. Arthritis Care Res (Hoboken) (2012) 1.06
SLE patients with renal damage incur higher health care costs. Rheumatology (Oxford) (2008) 1.06
Percutaneous vertebroplasty treatment of steroid-induced osteoporotic compression fractures. Arthritis Rheum (1998) 1.05
Studies on Nosema cuniculi found in transplantable ascites tumours with a survey of microsporidiosis in mammals. Acta Pathol Microbiol Scand Suppl (1969) 1.04
Estimating renal function in lupus nephritis: comparison of the Modification of Diet in Renal Disease and Cockcroft Gault equations. Lupus (2007) 1.04
Patterns of disease activity in systemic lupus erythematosus. Arthritis Rheum (1999) 1.03
Antinuclear antibody, lupus anticoagulant, and anticardiolipin antibody in women with idiopathic habitual abortion. A controlled, prospective study of forty-four women. Arthritis Rheum (1987) 1.03
Race/ethnicity and cancer occurrence in systemic lupus erythematosus. Arthritis Rheum (2005) 1.02
Is vasopressin involved in the pathogenesis of malignant desoxycorticosterone hypertension in rats? Lancet (1976) 1.02
Endpoints: consensus recommendations from OMERACT IV. Outcome Measures in Rheumatology. Lupus (2000) 1.01
Short-term outcome of neuropsychiatric events in systemic lupus erythematosus upon enrollment into an international inception cohort study. Arthritis Rheum (2008) 1.01
The effect of nutritional support on outcome from severe head injury. J Neurosurg (1987) 1.00
Autoantibodies in systemic lupus erythematosus: comparison of historical and current assessment of seropositivity. Lupus (2011) 1.00
Systemic Lupus International Collaborating Clinics conference on assessment of lupus flare and quality of life measures in SLE. Systemic Lupus International Collaborating Clinics Group. J Rheumatol (1996) 0.99
T helper cell dysfunction in systemic lupus erythematosus (SLE): relation to disease activity. J Clin Immunol (1994) 0.99
Wegener's granulomatosis: isolated involvement of the trachea and larynx. Ann Rheum Dis (1987) 0.98
Reference range for serum cortisol in well preterm infants. Arch Dis Child Fetal Neonatal Ed (1999) 0.98
Clinical manifestations and coronary artery disease risk factors at diagnosis of systemic lupus erythematosus: data from an international inception cohort. Lupus (2007) 0.97
Analysis of polymorphisms affecting immune complex handling in systemic lupus erythematosus. Rheumatology (Oxford) (2003) 0.97
Correlation of serum measures of nitric oxide production with lupus disease activity. J Rheumatol (1999) 0.97
Disassociation of sex hormone levels and cytokine production in SLE patients. Lupus (2001) 0.96
Salt and water balance and renin activity in renal hypertension of rats. Am J Physiol (1975) 0.96
Complement receptor 2 polymorphisms associated with systemic lupus erythematosus modulate alternative splicing. Genes Immun (2009) 0.96
Effects of saline drinking on malignant course of renal hypertension in rats. Am J Physiol (1976) 0.96
Large intracranial arteritis with giant cells in systemic lupus erythematosus. Ann Intern Med (1986) 0.95
Potassium deficiency in rats with hereditary diabetes insipidus. Am J Physiol (1974) 0.95
Thrombosis and systemic lupus erythematosus: the Hopkins Lupus Cohort perspective. Scand J Rheumatol (1996) 0.95
Digital necrosis: a paraneoplastic syndrome. J Rheumatol (1985) 0.95
Diagnosis of rotator cuff lesions: comparison of US and MRI on 38 joint specimens. Eur Radiol (1997) 0.95
Cardiac disease in the antiphospholipid syndrome: recommendations for treatment. Committee consensus report. Lupus (2003) 0.95
Failure of prophylactically administered phenytoin to prevent early posttraumatic seizures. J Neurosurg (1983) 0.94
The incidence of granulomas in serial sections of rectal biopsies from patients with Crohn's disease. Acta Pathol Microbiol Immunol Scand A (1982) 0.94